Baird Upgrades ResMed (RMD) to Outperform
- Futures drop as Middle East tensions simmer, Netflix slumps
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Stocks off two-month low as fear of Middle East escalation eases
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Oil slips despite reported Israeli attack on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
ResMed (RMD) Receives Two Wall Street Upgrades as Rival Philips Deals with Expanded Recalls
January 13, 2022 9:04 AM ESTResMed (NYSE: RMD) shares were upgraded by two separate analysts Thursday as the company is seen as a beneficiary to rival Philips' expanded CPAP, BiPAP and Mechanical Ventilator recall from 4 million to 5.2 million devices, while it only has about 1.5 million repair and replace... More
ResMed (RMD) PT Raised to $234 at RBC Capital on More Philips Woes
January 13, 2022 7:32 AM ESTRBC Capital analyst Craig Wong-Pan raised the price target on ResMed (NYSE: RMD) to $234.00 (from $227.00) while maintaining an Underperform rating after rival Philips recalled expanded to 5.2 million devices "and the cadence of manufacturing repair kits and replacement devices was slightly slower than we expected."
... More